End-O Check will provide risk-based assessments, diagnostic testing, and symptom evaluation for women, particularly those in the postmenopausal age group
Navi Mumbai, 30 July 2025 ( TGN ) : Reinforcing its commitment to preventive oncology for women, Apollo Cancer Centres (ACCs) today launched End-O Check, a comprehensive early detection program targeting women aged 45 and above. The initiative is designed to detect two of the most prevalent gynaecologic cancers—endometrial and ovarian—at an early and more treatable stage.
Ovarian cancer, often referred to as the “silent killer,” affects women between 55 and 64 years of age, with the average diagnosis occurring at 63. When caught early, the 5-year survival rate exceeds 90%.
In India, the total cancer cases are projected to grow to 1.57 million by 2025, with ovarian and uterine cancers continuing to report among the top 5 cancers affecting women. The age-standardized incidence rates are estimated at 4.6 per 100,000 for ovarian cancers and 2.5 per 100,000 for corpus uterinecancers2. Contributing factors include shifts in reproductive patterns, urban lifestyles, and a rise in metabolic conditions, highlighting the urgent need for targeted detection in high-risk populations.
While endometrial cancer often presents with symptoms such as unexpected bleeding or abnormal discharge, many women fail to report these signs early, leading to delayed diagnosis and poorer outcomes.
End-O Check is designed with a focus on early detection in high-risk populations, symptom awareness, and timely intervention, empowering women to take proactive steps for their gynaecologic health.
Speaking at the launch, Mr. Dinesh Madhavan, President, Group Oncology & International, Apollo Hospitals Enterprise Ltd, said, “Early detection remains our most powerful ally in improving survival and quality of life in cancer care. End O Check is a proactive step in shifting the narrative from treatment to screening and early diagnosis , enabling timely detection, and precision treatment by cancer management teams”
Dr Richa Bansal – Consultant Gynec Oncology, Laparoscopic & Robotic Surgery Apollo Cancer Centers Mumbai said, “Endometrial cancer has been on the rise in women above the age of 45 years, so early detection is crucial for better outcomes. Global data indicates a 5 year survival rate of around 96% for localized disease. However, survival rates drop substantially when diagnosis is delayed, underscoring the importance of timely detection. Key risk factors include obesity, diabetes, early menstruation, late menopause, and polycystic ovary syndrome (PCOS), all of which are becoming more prevalent among Indian women.”
Dr Bindhu KS – Sr. Consultant Dept of Ob Gyn & Robotic Surgery, Apollo Hospitals Navi Mumbai said, “Radiology plays a crucial role in the early detection of gynaecologic cancers. Through End-O Check, we are integrating transvaginal ultrasonography (TVS) as the diagnostic tool to help identify subtle changes that could indicate early-stage ovarian or endometrial cancers. Early imaging intervention allows clinicians to act promptly, improving treatment options and outcomes for patients.”
Dr Anil D’cruz –Director Oncology & Sr Head & Neck Onco Surgeon Apollo Cancer Centres, added, “With End O Check, we are expanding our preventive oncology efforts. This program is about creating sustained awareness, encouraging women to prioritize their health, and ensuring equitable access to reliable cancer detection tools. Early detection not only saves lives—it also enables less invasive, more effective treatment options.”
